| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| SLP(L) | 87 | 31.3% | 0.67 | 138 | 73.8% |
| LH(L) | 160 | 57.6% | -1.93 | 42 | 22.5% |
| CentralBrain-unspecified | 31 | 11.2% | -2.15 | 7 | 3.7% |
| upstream partner | # | NT | conns CB3393 | % In | CV |
|---|---|---|---|---|---|
| LHAV4b2 (L) | 5 | GABA | 36 | 13.6% | 0.5 |
| VA1v_adPN (L) | 4 | ACh | 34 | 12.9% | 0.4 |
| DA2_lPN (L) | 4 | ACh | 11 | 4.2% | 0.7 |
| LHAV3e4_b (L) | 1 | ACh | 10 | 3.8% | 0.0 |
| VM6_lvPN (L) | 2 | ACh | 8 | 3.0% | 0.2 |
| VA7m_lPN (L) | 3 | ACh | 8 | 3.0% | 0.6 |
| AVLP595 (L) | 1 | ACh | 7 | 2.7% | 0.0 |
| LHAV3e4_a (L) | 1 | ACh | 7 | 2.7% | 0.0 |
| VA6_adPN (L) | 1 | ACh | 7 | 2.7% | 0.0 |
| VM6_adPN (L) | 1 | ACh | 7 | 2.7% | 0.0 |
| DL3_lPN (L) | 3 | ACh | 7 | 2.7% | 0.5 |
| VM5d_adPN (L) | 1 | ACh | 6 | 2.3% | 0.0 |
| AVLP267 (L) | 1 | ACh | 5 | 1.9% | 0.0 |
| VM1_lPN (L) | 1 | ACh | 5 | 1.9% | 0.0 |
| CB1276 (L) | 3 | ACh | 5 | 1.9% | 0.3 |
| LHAV2b10 (L) | 1 | ACh | 4 | 1.5% | 0.0 |
| LHAV4c1 (L) | 1 | GABA | 4 | 1.5% | 0.0 |
| VM5v_adPN (L) | 1 | ACh | 4 | 1.5% | 0.0 |
| LHPV6a1 (L) | 3 | ACh | 4 | 1.5% | 0.4 |
| SMP252 (L) | 1 | ACh | 3 | 1.1% | 0.0 |
| AVLP595 (R) | 1 | ACh | 3 | 1.1% | 0.0 |
| CB3255 (L) | 2 | ACh | 3 | 1.1% | 0.3 |
| CB1503 (L) | 1 | Glu | 2 | 0.8% | 0.0 |
| CB2678 (L) | 1 | GABA | 2 | 0.8% | 0.0 |
| M_imPNl92 (R) | 1 | ACh | 2 | 0.8% | 0.0 |
| CB1359 (L) | 1 | Glu | 2 | 0.8% | 0.0 |
| AVLP227 (L) | 1 | ACh | 2 | 0.8% | 0.0 |
| CB2861 (L) | 1 | unc | 2 | 0.8% | 0.0 |
| CB4116 (L) | 1 | ACh | 2 | 0.8% | 0.0 |
| CB4132 (L) | 1 | ACh | 2 | 0.8% | 0.0 |
| CB2196 (L) | 1 | Glu | 2 | 0.8% | 0.0 |
| LHPV2a1_c (L) | 1 | GABA | 2 | 0.8% | 0.0 |
| LHAV2b7_b (L) | 1 | ACh | 2 | 0.8% | 0.0 |
| CB3218 (L) | 2 | ACh | 2 | 0.8% | 0.0 |
| CB2507 (L) | 2 | Glu | 2 | 0.8% | 0.0 |
| CB3016 (L) | 2 | GABA | 2 | 0.8% | 0.0 |
| LHAV1f1 (L) | 2 | ACh | 2 | 0.8% | 0.0 |
| CB2831 (L) | 2 | GABA | 2 | 0.8% | 0.0 |
| CB3261 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| LHPV4g2 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| LHPV4b4 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| LHAV4b4 (L) | 1 | GABA | 1 | 0.4% | 0.0 |
| LHCENT2 (L) | 1 | GABA | 1 | 0.4% | 0.0 |
| LHPV2a1_d (L) | 1 | GABA | 1 | 0.4% | 0.0 |
| CB1432 (L) | 1 | GABA | 1 | 0.4% | 0.0 |
| OA-VPM3 (L) | 1 | OA | 1 | 0.4% | 0.0 |
| CB3075 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| LHPD4a1 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| CB3729 (L) | 1 | unc | 1 | 0.4% | 0.0 |
| LHAV2b6 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| SLP129_c (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| CB1529 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| LHAV2c1 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| SLP079 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| LHAV4g7_a (L) | 1 | GABA | 1 | 0.4% | 0.0 |
| SLP395 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| LHAV4e2_b1 (L) | 1 | GABA | 1 | 0.4% | 0.0 |
| SLP400 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| CB2786 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| LHAV4d1 (L) | 1 | unc | 1 | 0.4% | 0.0 |
| LHAV4a4 (L) | 1 | GABA | 1 | 0.4% | 0.0 |
| M_lvPNm46 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| M_vPNml67 (L) | 1 | GABA | 1 | 0.4% | 0.0 |
| LHAV3o1 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| CB2045 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| LHAV5c1 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| AVLP306 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| M_VPNml66 (L) | 1 | GABA | 1 | 0.4% | 0.0 |
| LHPV7b1 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| CL073 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| LHAV2m1 (L) | 1 | GABA | 1 | 0.4% | 0.0 |
| LHPV2h1 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| DC2_adPN (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| DA1_vPN (L) | 1 | GABA | 1 | 0.4% | 0.0 |
| AVLP343 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| LHCENT5 (L) | 1 | GABA | 1 | 0.4% | 0.0 |
| LHCENT6 (L) | 1 | GABA | 1 | 0.4% | 0.0 |
| DL1_adPN (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| DL4_adPN (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| LHCENT8 (L) | 1 | GABA | 1 | 0.4% | 0.0 |
| DA4m_adPN (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| VL2p_adPN (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| downstream partner | # | NT | conns CB3393 | % Out | CV |
|---|---|---|---|---|---|
| SMP255 (L) | 1 | ACh | 36 | 10.0% | 0.0 |
| CB3261 (L) | 2 | ACh | 24 | 6.7% | 0.7 |
| SLP400 (L) | 2 | ACh | 21 | 5.8% | 0.3 |
| LHAV2b10 (L) | 2 | ACh | 19 | 5.3% | 0.2 |
| SLP281 (L) | 1 | Glu | 17 | 4.7% | 0.0 |
| LHAV1a1 (L) | 4 | ACh | 17 | 4.7% | 0.3 |
| LHAV2b6 (L) | 3 | ACh | 13 | 3.6% | 0.5 |
| AVLP267 (L) | 1 | ACh | 11 | 3.1% | 0.0 |
| LHAV4e2_b1 (L) | 2 | GABA | 11 | 3.1% | 0.6 |
| CL032 (L) | 1 | Glu | 9 | 2.5% | 0.0 |
| AVLP042 (L) | 2 | ACh | 9 | 2.5% | 0.6 |
| CL073 (L) | 1 | ACh | 8 | 2.2% | 0.0 |
| AVLP225_b3 (L) | 1 | ACh | 7 | 1.9% | 0.0 |
| SLP061 (L) | 1 | GABA | 7 | 1.9% | 0.0 |
| SLP007 (L) | 1 | Glu | 6 | 1.7% | 0.0 |
| SMP219 (L) | 1 | Glu | 6 | 1.7% | 0.0 |
| CB1701 (L) | 2 | GABA | 6 | 1.7% | 0.3 |
| LHAD1b1_b (L) | 3 | ACh | 6 | 1.7% | 0.0 |
| SLP109 (L) | 1 | Glu | 5 | 1.4% | 0.0 |
| SLP012 (L) | 2 | Glu | 5 | 1.4% | 0.6 |
| SLP457 (L) | 1 | unc | 4 | 1.1% | 0.0 |
| CB4151 (L) | 2 | Glu | 4 | 1.1% | 0.5 |
| LHAV2c1 (L) | 2 | ACh | 4 | 1.1% | 0.5 |
| LHAV1f1 (L) | 2 | ACh | 4 | 1.1% | 0.5 |
| LHPV5b1 (L) | 3 | ACh | 4 | 1.1% | 0.4 |
| LHAV4a4 (L) | 1 | GABA | 3 | 0.8% | 0.0 |
| SMP041 (L) | 1 | Glu | 3 | 0.8% | 0.0 |
| SMP026 (L) | 1 | ACh | 3 | 0.8% | 0.0 |
| CB2045 (L) | 1 | ACh | 3 | 0.8% | 0.0 |
| LHAV2b7_b (L) | 1 | ACh | 3 | 0.8% | 0.0 |
| CB1359 (L) | 2 | Glu | 3 | 0.8% | 0.3 |
| SLP129_c (L) | 2 | ACh | 3 | 0.8% | 0.3 |
| LHAD1d1 (L) | 1 | ACh | 2 | 0.6% | 0.0 |
| CL115 (L) | 1 | GABA | 2 | 0.6% | 0.0 |
| CB2298 (L) | 1 | Glu | 2 | 0.6% | 0.0 |
| LHPV6p1 (L) | 1 | Glu | 2 | 0.6% | 0.0 |
| CB2720 (L) | 1 | ACh | 2 | 0.6% | 0.0 |
| CB3729 (L) | 1 | unc | 2 | 0.6% | 0.0 |
| AVLP225_b2 (L) | 1 | ACh | 2 | 0.6% | 0.0 |
| CB2196 (L) | 1 | Glu | 2 | 0.6% | 0.0 |
| SLP222 (L) | 1 | ACh | 2 | 0.6% | 0.0 |
| DL3_lPN (L) | 1 | ACh | 2 | 0.6% | 0.0 |
| VA1v_adPN (L) | 1 | ACh | 2 | 0.6% | 0.0 |
| SLP060 (L) | 1 | GABA | 2 | 0.6% | 0.0 |
| AVLP571 (L) | 1 | ACh | 2 | 0.6% | 0.0 |
| VM6_adPN (L) | 1 | ACh | 2 | 0.6% | 0.0 |
| LHPV12a1 (L) | 1 | GABA | 2 | 0.6% | 0.0 |
| LHPV4a1 (L) | 2 | Glu | 2 | 0.6% | 0.0 |
| CB1289 (L) | 2 | ACh | 2 | 0.6% | 0.0 |
| CB3036 (L) | 2 | GABA | 2 | 0.6% | 0.0 |
| LHAV4d1 (L) | 2 | unc | 2 | 0.6% | 0.0 |
| SLP230 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| SMP495_c (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| PLP002 (L) | 1 | GABA | 1 | 0.3% | 0.0 |
| PLP067 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| SLP152 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| SLP456 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| LHPV5b2 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| CB3240 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| SLP375 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| LHAV4e7_b (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| AVLP049 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| CB2678 (L) | 1 | GABA | 1 | 0.3% | 0.0 |
| SMP171 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| LHPV6a1 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| CL024_a (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| CB1590 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| SMP314 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| CB2983 (L) | 1 | GABA | 1 | 0.3% | 0.0 |
| LHPD4b1 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| CB3268 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| LHAV4b2 (L) | 1 | GABA | 1 | 0.3% | 0.0 |
| SMP159 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| LHPD5e1 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| LHAV2a5 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| SLP099 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| AVLP306 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| CL072 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| SMP042 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| LHPV2h1 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| LHAV3f1 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| LHAV5a8 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| AVLP343 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| LHCENT8 (L) | 1 | GABA | 1 | 0.3% | 0.0 |
| DL4_adPN (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| AVLP211 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| SMP527 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| CSD (R) | 1 | 5-HT | 1 | 0.3% | 0.0 |
